Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report

Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary reportGenetics of response to cognitive behavior therapy in adults with major depression: a preliminary report, Published online: 08 November 2018; doi:10.1038/s41380-018-0289-9Major depressive disorder is heritable and a leading cause of disability. Cognitive behavior therapy is an effective treatment for major depression. By quantifying genetic risk scores based on common genetic variants, the aim of this report was to explore the utility of psychiatric and cognitive trait genetic risk scores, for predicting the response of 894 adults with major depressive disorder to cognitive behavior therapy. The participants were recruited in a psychiatric setting, and the primary outcome score was measured using the Montgomery Åsberg Depression Rating Scale-Self Rated. Single-nucleotide polymorphism genotyping arrays were used to calculate the genomic risk scores based on large genetic studies of six phenotypes: major depressive disorder, bipolar disorder, attention-deficit/hyperactivity disorder, autism spectrum disorder, intelligence, and educational attainment. Linear mixed-effect models were used to test the relationships between the six genetic risk scores and cognitive behavior therapy outcome. Our analyses yielded one significant interaction effect (B = 0.09, p
Source: Molecular Psychiatry - Category: Psychiatry Authors: Source Type: research